lanthanum carbonate od tablets 250mg "fuso" (炭酸ランタンod錠250mg「フソー」)
fuso pharmaceutical industries, ltd. - lanthanum carbonate hydrate - white to grayish white tablets, diameter: 10.5 mm, thickness: 4.6 mm
lanthanum carbonate od tablets 250mg "jg" (炭酸ランタンod錠250mg「jg」)
nihon generic co.,ltd - lanthanum carbonate hydrate - white to grayish white tablets, diameter: 10.5 mm, thickness: 4.6mm
lanthanum carbonate od tablets 500mg "fuso" (炭酸ランタンod錠500mg「フソー」)
fuso pharmaceutical industries, ltd. - lanthanum carbonate hydrate - white to grayish white tablets, diameter: 13 mm, thickness: 5.4 mm
lanthanum carbonate od tablets 500mg "jg" (炭酸ランタンod錠500mg「jg」)
nihon generic co.,ltd - lanthanum carbonate hydrate - white to grayish white tablets, diameter: 13 mm, thickness: 5.4 mm
pharmachem halothane bp
pharmachem australia pty ltd - halothane - parenteral liquid/solution/suspension - halothane anaesthetic active 1.0 ml/ml - anaesthetics/analgesics - cat | dog | horse | bitch | castrate | cat - queen | cat - tom | colt | donkey | endurance horse | filly | foal | gelding | high - anaesthetic - local/general | general anaesthetic | immobiliser | local anaesthetic | premedication | sedative | tranquilliser | travel sickness
halothane-vet 100% inhalation vapour, liquid
merial animal health limited - halothane - inhalation vapour, solution - neurological agent general anaesthetic - all animals, horses
halothane m & b
sanofi-aventis new zealand limited - halothane - volatile liquid for inhalation - active: halothane
lanthanum carbonate 750 mg chewable tablets
viatris limited damastown industrial park, mulhuddart, dublin 15, dublin, ireland - chewable tablet - lanthanum 750 mg - all other therapeutic products
halothane 250ml
piramal healthcare ltd - halothane - liquid - each 250ml bottle contains 100%v/v halothane
fosrenol 1000 mg oral powder
takeda israel ltd - lanthanum as carbonate hydrate - powder - lanthanum as carbonate hydrate 1000 mg - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd). fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels ≥ 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.